ACTUMED
ActiveSummary
ACTUMED has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €13,970 and a net result of €941. Equity has been stable since 2023 (±2.1% per year). Its solvency ranks better than 37% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 20-01-2023 Normal situation
- Registered office
- 17 active companies are registered at this address 1 started in the 12 months before. Source: KBO register, as of 2 November 2026.
- Activity
- Specialist medical practice NACE 86220
- Establishment unit
- 2.340.624.252 1080 Sint-Jans-Molenbeek, since 20-01-2023
- Financial year end
- 31 December
- Peppol
- Reachable since 19-12-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
- Gross margin
- €32,901
- ▲ 50.6%
- Turnover
- ≈ €100,000
- estimated
- Profit
- €941
- Equity
- €13,970
- ▲ 7.2%
- Total assets
- €29,951
- ▲ 38.8%
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.70, cash €16,850Figures for financial year 2025 (filed on 24-07-2026)Size: total assets €29,951Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 37% of them on solvency, 56% on liquidity, 6% on profitability and 49% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 3 accounts on average 6 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
Financials
Financials · financial year 2025, micro format
Annual accounts 2025 filed on 24-07-2026 at the NBB all 3 filings
2023 to 2025, 3 financial years
The operating result for 2025 is 54% higher than in 2024 and the highest since 2023. It is the second rise in a row.
Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.
Assets, equity and debt per financial year.
Above zero, the company can pay its short-term debts with what it holds in the short term.
The EBIT margin is the share of each euro of turnover left from operations. The return on assets is what the assets earn.
The higher the solvency, the better the company absorbs a setback.
A ratio above 1 means the short-term assets cover the short-term debts.
Use the arrow keys on the chart for the figures per year.
The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30. The dashed line is the median. There is a sector band for net result, equity, total assets, working capital, solvency, current ratio and return on assets (ROA).
Investments
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Tangible fixed assets | €5,247 | €500 | €1,850 |
| Financial fixed assets | - | - | €0 |
| Depreciation and write-downs of the year | €758 | €1,339 | €1,552 |
Source: notes to the 2023 to 2025 annual accounts (statement of fixed assets)
Comparable companies
These companies have the same main activity as ACTUMED: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €29,500 and €42,900, founded between 2021 and 2024.
| Company | Founded | Total assets | Equity | Gross margin | Net result | Financial year |
|---|---|---|---|---|---|---|
| ACTUMED Sint-Jans-Molenbeek | 2023 | €29,951 | €13,970 | €32,901 | €941 | 2025 |
| DOKTER MAGALIE DE KEZEL Gent | 2023 | €38,124 | €27,722 | €29,582 | €18,597 | 2025 |
| DOCTEUR BIERLAIRE STEPHANIE Nivelles | 2024 | €38,102 | €27,415 | €31,136 | €19,778 | 2025 |
| CABINET KARIBOU Anderlecht | 2021 | €34,488 | €1,000 | €41,012 | €8,688 | 2025 |
| CABINET DE GYNECOLOGIE DOBRESCU Brussel | 2021 | €30,210 | €16,133 | €45,949 | €2,690 | 2025 |
| Dr. Francesca Donders Jette | 2024 | €42,916 | €27,243 | €34,592 | €26,243 | 2025 |
| Stethic Aartselaar | 2023 | €29,534 | €26,598 | €24,847 | €16,350 | 2025 |
They were chosen from the 8,159 other active companies with that main activity and annual accounts from the past two years. All companies with this main activity
Companies with the same profile, two years later
Historical observationIn July 2024, 2,546 companies had the same profile as ACTUMED has now. Two years later, 2.3% had gone bankrupt and 94.3% were still going.
- Micro
- 2 to 5 years old
- solvency 30% or more
- a profit under 5% of the balance sheet
Another 0.2% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of ACTUMED itself is lower: < 0.1% within 12 months. It rests on far more data about ACTUMED than the profile alone.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,546 companies, not a prediction for ACTUMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €758 | €1,339 | €1,552 | ▲ 16.0% |
| Other operating charges640/8 | €770 | €316 | €326 | ▲ 3.2% |
| Gross operating margin9900 | €19,796 | €21,848 | €32,901 | ▲ 50.6% |
| Operating profit (loss)9901 | €18,268 | €20,193 | €31,023 | ▲ 53.6% |
| Financial income75/76B | - | - | €1 | - |
| Recurring financial income75 | - | - | €1 | - |
| Financial charges65/66B | €51 | €21,245 | €28,689 | ▲ 35.0% |
| Recurring financial charges65 | €51 | €21,245 | €28,689 | ▲ 35.0% |
| Profit (loss) for the period before taxes9903 | €18,217 | -€1,052 | €2,334 | - |
| Income taxes67/77 | €5,360 | €476 | €1,393 | ▲ 193% |
| Profit (loss) for the period9904 | €12,857 | -€1,528 | €941 | - |
| Profit (loss) for the period to be appropriated9905 | €12,857 | -€1,528 | €941 | - |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Assets | ||||
| Total assets20/58 | €22,745 | €21,576 | €29,951 | ▲ 38.8% |
| Fixed assets21/28 | €4,489 | €3,651 | €3,949 | ▲ 8.2% |
| Tangible fixed assets22/27 | €4,489 | €3,651 | €3,949 | ▲ 8.2% |
| Furniture and vehicles24 | €4,489 | €3,651 | €3,949 | ▲ 8.2% |
| Current assets29/58 | €18,256 | €17,925 | €26,002 | ▲ 45.1% |
| Amounts receivable within one year40/41 | €782 | €3,861 | €2,892 | ▼ 25.1% |
| Trade receivables40 | €782 | €1,280 | €250 | ▼ 80.5% |
| Other amounts receivable41 | - | €2,581 | €2,642 | ▲ 2.3% |
| Cash at bank and in hand54/58 | €8,282 | €13,066 | €16,850 | ▲ 29.0% |
| Deferred charges and accrued income490/1 | €9,193 | €998 | €6,261 | ▲ 527% |
| Equity and liabilities | ||||
| Total equity and liabilities10/49 | €22,745 | €21,576 | €29,951 | ▲ 38.8% |
| Equity10/15 | €14,557 | €13,029 | €13,970 | ▲ 7.2% |
| Contributions10/11 | €2,500 | €2,500 | €2,500 | = |
| Reserves13 | €12,057 | €12,057 | €12,057 | = |
| Distributable reserves133 | €12,057 | €12,057 | €12,057 | = |
| Profit (loss) carried forward14 | - | -€1,528 | -€586 | ▲ 61.6% |
| Amounts payable17/49 | €8,189 | €8,547 | €15,981 | ▲ 87.0% |
| Amounts payable within one year42/48 | €8,189 | €7,427 | €15,340 | ▲ 107% |
| Trade debts44 | €1,345 | €217 | €86 | ▼ 60.2% |
| Suppliers440/4 | €1,345 | €217 | €86 | ▼ 60.2% |
| Taxes, remuneration and social security45 | €5,360 | €636 | €1,031 | ▲ 62.1% |
| Taxes450/3 | €5,360 | €476 | €1,031 | ▲ 117% |
| Remuneration and social security454/9 | - | €160 | €0 | ▼ 100% |
| Other amounts payable47/48 | €1,483 | €6,575 | €14,224 | ▲ 116% |
| Accrued charges and deferred income492/3 | - | €1,120 | €641 | ▼ 42.8% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Profit (loss) for the period9904 | €12,857 | -€1,528 | €941 | - |
| + Depreciation and write-downs630 | €758 | €1,339 | €1,552 | ▲ 16.0% |
| Operating cash flow (approximation) | €13,614 | -€189 | €2,494 | - |
| Investment in fixed assets (approximation) | - | -€500 | -€1,850 | ▼ 270% |
| Change in cash | - | €4,784 | €3,784 | ▼ 20.9% |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Board & ownership
Directors
Owners and capital
Shareholders
- TOUZANI Sara 100 shares (100%) · €2,500
Capital transactions
- 24-01-2023 Incorporation · €2,500 · 100 shares
Articles of association
Board and representation
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Nommés avec ou sans limitation de durée, 10”
Capital, shares and profit
- Kind of sharesThe articles set which classes of shares exist and what rights each class carries.
- “Nominatives, 8”
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Frais procédure et expertise pour moitié à charge cédant et moitié à charge acquéreurs proportionnellement au nombre d'actions acquises…”
- Share issue ruleThe articles set how and by whom new shares are issued.
- “Actions nouvelles à souscrire en numéraire offertes par préférence aux actionnaires existants proportionnellement au nombre d'actions…”
Articles of association, deed of 24-01-2023 (in French)
Network & group
ACTUMED shares no director with another company.
Companies at the same address
16 other companies- NUBIAN CARE Registered office · since 2026 1037609592
- Vanhecke, Keny (sole trader) Establishment · since 2025 1028588097
- Garnisseur Dias Registered office · since 2024 1007420323
- BAMIKA Registered office · since 2023 0804027654
- Catcostconsult Registered office · since 2023 0800092820
- Chivu, Nicuşor (sole trader) Establishment · since 2020 0540653650
- Whinsprattack International Registered office · since 2016 0651810504
- JURIFIL CONSULT Registered office · since 2015 0640740527
- ZERRIN Registered office · since 2014 0546854722
- ANTONI ENTREPRISES Registered office · since 2013 0533735471
Connections & network
1 current directorThe network starts from the directors of ACTUMED. Every other company they run is a node.
Timeline
Acts, filings and financial milestones
24-01
Gazette deed
IncorporationStarting capital €2,500 · Appointment: TOUZANI Sara (director) · Founder16 points ▸
- Founder, TOUZANI Sara (comparant)
- Other provision, “capacité et identité des comparants, Notaire instrumentant” (deed in French)
- Other provision, “commentaire et lecture de l'acte” (deed in French)
- Other provision, “projet d'acte et dispense de lecture intégrale” (deed in French)
- Incorporation, “ACTUMED” (deed in French)
- Founding capital, €2,500
- Bank account, “KBC Brussels, BE06 7310 5455 7522” (deed in French)
- Other provision, “plan financier et responsabilité des fondateurs”, 19-01-2023 (deed in French)
- Other provision, “attestation du dépôt en espèces”, EUR (deed in French)
- Other provision, “arrêt des statuts, CHAPITRE II : STATUTS” (deed in French)
- Capital, €2,500
- Registered office clause, “pas encore, 1080 Molenbeek-Saint-Jean,Boulevard Louis Mettewie,56 bte 0039” (deed in French)
- The act holds 4 more points.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordRegistered office and establishments
Activities
NACEBEL 2025Codes under NACEBEL 2008
Invoicing and payment
Financial year and general meeting
Accounts at the NBBRecognitions · licences · registrations
Legal Entity Identifier
Sites & property
Buildings and parcels at the address
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 21524C0210/00C003 | Brussels | 4,797 m² | 1 · 534 m² | 30.1 m · 9 |